Cargando…

A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol

N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyano...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukamatsu, Fumiaki, Sugiura, Kazusa, Takekoshi, Daiya, Fukuzawa, Takuya, Oyama, Kazuki, Tsukahara, Yoshinori, Kurozumi, Masahiro, Shimizu, Akira, Fujinaga, Yasunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172629/
https://www.ncbi.nlm.nih.gov/pubmed/37179814
http://dx.doi.org/10.1016/j.radcr.2023.04.005
_version_ 1785039649006157824
author Fukamatsu, Fumiaki
Sugiura, Kazusa
Takekoshi, Daiya
Fukuzawa, Takuya
Oyama, Kazuki
Tsukahara, Yoshinori
Kurozumi, Masahiro
Shimizu, Akira
Fujinaga, Yasunari
author_facet Fukamatsu, Fumiaki
Sugiura, Kazusa
Takekoshi, Daiya
Fukuzawa, Takuya
Oyama, Kazuki
Tsukahara, Yoshinori
Kurozumi, Masahiro
Shimizu, Akira
Fujinaga, Yasunari
author_sort Fukamatsu, Fumiaki
collection PubMed
description N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyanoacrylate–Lipiodol–Iopamidol has lower adhesiveness than N-butyl cyanoacrylate–Lipiodol mixture and the ability to form a single large droplet. We report the case of a 63-year-old man with a ruptured splenic artery aneurysm treated by transcatheter arterial embolization using N-butyl cyanoacrylate–Lipiodol–Iopamidol. He was referred to the emergency room because of sudden onset of upper abdominal pain. A diagnosis was established using contrast-enhanced computed tomography and angiography. Emergency transcatheter arterial embolization was performed, and the ruptured splenic artery aneurysm was successfully embolized using a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamidol packing. This case demonstrates the usefulness of a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamdol packing for the embolization of aneurysms.
format Online
Article
Text
id pubmed-10172629
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101726292023-05-12 A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol Fukamatsu, Fumiaki Sugiura, Kazusa Takekoshi, Daiya Fukuzawa, Takuya Oyama, Kazuki Tsukahara, Yoshinori Kurozumi, Masahiro Shimizu, Akira Fujinaga, Yasunari Radiol Case Rep Case Report N-butyl cyanoacrylate, one of embolic materials, is usually used as a mixture with Lipiodol (N-butyl cyanoacrylate–Lipiodol mixture). N-butyl cyanoacrylate–Lipiodol–Iopamidol was developed by adding a nonionic iodine contrast agent (Iopamiron) to N-butyl cyanoacrylate–Lipiodol mixture. N-butyl cyanoacrylate–Lipiodol–Iopamidol has lower adhesiveness than N-butyl cyanoacrylate–Lipiodol mixture and the ability to form a single large droplet. We report the case of a 63-year-old man with a ruptured splenic artery aneurysm treated by transcatheter arterial embolization using N-butyl cyanoacrylate–Lipiodol–Iopamidol. He was referred to the emergency room because of sudden onset of upper abdominal pain. A diagnosis was established using contrast-enhanced computed tomography and angiography. Emergency transcatheter arterial embolization was performed, and the ruptured splenic artery aneurysm was successfully embolized using a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamidol packing. This case demonstrates the usefulness of a combination of coil framing and N-butyl cyanoacrylate–Lipiodol–Iopamdol packing for the embolization of aneurysms. Elsevier 2023-04-29 /pmc/articles/PMC10172629/ /pubmed/37179814 http://dx.doi.org/10.1016/j.radcr.2023.04.005 Text en © 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Fukamatsu, Fumiaki
Sugiura, Kazusa
Takekoshi, Daiya
Fukuzawa, Takuya
Oyama, Kazuki
Tsukahara, Yoshinori
Kurozumi, Masahiro
Shimizu, Akira
Fujinaga, Yasunari
A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title_full A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title_fullStr A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title_full_unstemmed A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title_short A ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–Lipiodol–Iopamidol
title_sort ruptured splenic artery aneurysm treated by transcatheter arterial embolization using n-butyl cyanoacrylate–lipiodol–iopamidol
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172629/
https://www.ncbi.nlm.nih.gov/pubmed/37179814
http://dx.doi.org/10.1016/j.radcr.2023.04.005
work_keys_str_mv AT fukamatsufumiaki arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT sugiurakazusa arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT takekoshidaiya arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT fukuzawatakuya arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT oyamakazuki arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT tsukaharayoshinori arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT kurozumimasahiro arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT shimizuakira arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT fujinagayasunari arupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT fukamatsufumiaki rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT sugiurakazusa rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT takekoshidaiya rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT fukuzawatakuya rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT oyamakazuki rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT tsukaharayoshinori rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT kurozumimasahiro rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT shimizuakira rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol
AT fujinagayasunari rupturedsplenicarteryaneurysmtreatedbytranscatheterarterialembolizationusingnbutylcyanoacrylatelipiodoliopamidol